Author:
Lam A. S. K.,Puncher M. R. B.,Blower P. J.
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine
Reference34 articles.
1. Ohta H, Yamamoto K, Endo K, et al. A new imaging agent for medullary carcinoma of the thyroid.J Nucl Med 1984; 25: 323?325.
2. Clarke SEM, Lazarus CR, Mistry R, Maisey MN. The role of technetium-99m pentavalent DMSA in the management of patients with medullary carcinoma of the thyroid.Br J Radiol 1987; 60: 1089?1092.
3. Clarke SEM, Lazarus CR, Wraight P, Sampson C, Maisey MN. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP ? an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.J Nucl Med 1988; 29: 33?38.
4. Patel MC, Patel RB, Ramanathan P, Ramamoorthy N, Krishna BA, Sharma SM. Clinical evaluation of99mTc(V)-dimercapto succinic acid (DMSA) for imaging medullary carcinoma of thyroid and its metastasis.Eur J Nucl Med 1988; 13: 507?510.
5. Ohta H, Endo K, Kanoh T, Konishi J, Kotoura H. Technetium-99m (V)DMSA uptake in amyloidosis.J Nucl Med 1989; 30: 2049?2052.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献